
Reset all filters
01 1DICLOFENAC SODIUM
02 1GABAPENTIN
03 1LEVETIRACETAM
04 3MORPHINE SULFATE
05 1MS CONTIN
06 1RITALIN
07 1RITALIN-SR
08 1VENLAFAXINE HYDROCHLORIDE
Reset all filters
01 110187
02 118029
03 119516
04 174769
05 174862
06 176201
07 190174
08 1202167
09 1203849
10 1204989
Reset all filters
01 10No
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 203849
Country : US
Patented : No
Drug : DICLOFENAC SODIUM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76201
Country : US
Patented : No
Drug : RITALIN-SR
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 18029
Country : US
Patented : No
Drug : MS CONTIN
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 19516
Country : US
Patented : No
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 74862
Country : US
Patented : No
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 74769
Country : US
Patented : No
Drug : RITALIN
Dosage Form : TABLET; ORAL
Application Number : 10187
Country : US
Patented : No
Drug : GABAPENTIN
Dosage Form : CAPSULE; ORAL
Application Number : 204989
Country : US
Patented : No
Drug : VENLAFAXINE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 90174
Country : US
Patented : No
Drug : LEVETIRACETAM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202167
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF